Aligning Policy to Promote Cascade Genetic Screening for Prevention and Early Diagnosis of Heritable Diseases

作者: Rani George , Karen Kovak , Summer L. Cox

DOI: 10.1007/S10897-014-9805-5

关键词:

摘要: Cascade genetic screening is a methodology for identifying and testing close blood relatives of individuals at increased risk heritable conditions follows sequential process, minimizing costs the number family members who need to be tested. It offers considerable potential cost savings awareness within families. CDC-classified Tier 1 genomic applications hereditary breast ovarian cancer syndrome (HBOC), Lynch Syndrome (LS), familial hypercholesterolemia (FH) are recommended clinical use support cascade screening. Most unaware their such as HBOC, LS, FH. Consistent implementation could significantly increase prevention conditions. Limitations effective include: insufficient assessment knowledge by majority healthcare providers without genetics credentials; shortage specialists, especially in rural areas; low rate reimbursement comprehensive counseling services; an individual focus on guidelines insurance coverage. The family-centric approach improves early diagnosis diseases population health level. better supported augmented through changes policy.

参考文章(44)
Peter Beighton, Greta Beighton, de la Chapelle, A. The Person Behind the Syndrome. pp. 209- 209 ,(1997) , 10.1007/978-1-4471-0925-9_118
Katrina F. Trivers, Laura-Mae Baldwin, Jacqueline W. Miller, Barbara Matthews, C. Holly A. Andrilla, Denise M. Lishner, Barbara A. Goff, Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians Cancer. ,vol. 117, pp. 5334- 5343 ,(2011) , 10.1002/CNCR.26166
Kory Jasperson, Colorectal cancer: Cascade genetic testing in Lynch syndrome: room for improvement. Nature Reviews Gastroenterology & Hepatology. ,vol. 10, pp. 506- 508 ,(2013) , 10.1038/NRGASTRO.2013.122
Karina L. Brierley, Erica Blouch, Whitney Cogswell, Jeanne P. Homer, Debbie Pencarinha, Christine L. Stanislaw, Ellen T. Matloff, Adverse events in cancer genetic testing: medical, ethical, legal, and financial implications. Cancer Journal. ,vol. 18, pp. 303- 309 ,(2012) , 10.1097/PPO.0B013E3182609490
Tracy A. Bensend, Patricia McCarthy Veach, Kristin B. Niendorf, What's the harm? Genetic counselor perceptions of adverse effects of genetics service provision by non-genetics professionals. Journal of Genetic Counseling. ,vol. 23, pp. 48- 63 ,(2014) , 10.1007/S10897-013-9605-3
Cheryl B. Crotser, Suzanne S. Dickerson, Learning about a twist in the road: perspectives of at-risk relatives learning of potential for cancer. Oncology Nursing Forum. ,vol. 37, pp. 723- 733 ,(2010) , 10.1188/10.ONF.723-733
Laura E. Forrest, Martin B. Delatycki, Lisette Curnow, Loane Skene, MaryAnne Aitken, Genetic health professionals and the communication of genetic information in families: Practice during and after a genetic consultation. American Journal of Medical Genetics Part A. ,vol. 152, pp. 1458- 1466 ,(2010) , 10.1002/AJMG.A.33385
Elizabeth McPherson, Christina Zaleski, Katrina Benishek, Catherine A McCarty, Philip F Giampietro, Kara Reynolds, Kristen Rasmussen, Clinical Genetics Provider Real-Time Workflow Study Genetics in Medicine. ,vol. 10, pp. 699- 706 ,(2008) , 10.1097/GIM.0B013E318182206F